NASHVILLE, TN. (April 1, 2024) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased to announce...
Aegis recently conducted a retrospective analysis of patient samples from individuals who were prescribed buprenorphine to ascertain how frequently novel...
NASHVILLE, TN. (February 5, 2024) – Nearly 107,000 Americans died from a drug overdose in 2021, according to the Centers for Disease...
Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill), the cannabis industry has seen widespread growth in...
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight...
Sign up for the Aegis Newsletter